NCT03052582

Brief Summary

The aim of the project is to investigate the effects in humans of a daily intake of whole milk compared to skimmed milk primarily and secondarily respectively on:

  • Blood lipids: total-, LDL-, and HDL-cholesterol and triglycerides
  • Risk markers of diabetes type 2: plasma glucose and insulin

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

February 8, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 14, 2017

Completed
Last Updated

April 2, 2018

Status Verified

March 1, 2018

Enrollment Period

2 months

First QC Date

February 8, 2017

Last Update Submit

March 30, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Fasting blood lipids

    total, LDL and HDL cholesterol and TAG

    3 weeks

Secondary Outcomes (2)

  • fasting plasma glucose

    3 weeks

  • fasting serum insulin

    3 weeks

Study Arms (2)

Team 1: skimmed/whole

ACTIVE COMPARATOR

Milktype: 3 weeks with skimmed milk followed by 3 weeks with whole milk

Other: Milk type

Team 2: whole/skimmed

ACTIVE COMPARATOR

Milktype: 3 weeks with whole milk followed by 3 weeks with skimmed milk

Other: Milk type

Interventions

Team 1: skimmed/wholeTeam 2: whole/skimmed

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All subjects must give their informed consent in writing, after having received oral and written information about the study
  • Age: 20-70 y
  • BMI: 18.5 - 30 kg/m2
  • Healthy men and women (with no known diseases)

You may not qualify if:

  • Current or previous cardiovascular disease, high blood pressure or cholesterol
  • Diabetes Mellitus or other severe chronic disease, including severe allergies
  • Lactose intolerant or milk allergy
  • Use of dietary supplements two month prior to and during the intervention Blood donations 1 month prior to and during the intervention
  • Known or suspected abuse of alcohol, drugs or medication
  • Pregnant or are planning pregnancy during the study period
  • Extreme physical activity level (more than 10 hours tough physical activity pr. week)
  • Participation in other research studies
  • Inability, physically or mentally, to comply with the procedures required by the study protocol, as evaluated by the study staff

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Nutrition, Exercise and Sports, University of Copenhagen

Copenhagen, 1958, Denmark

Location

Related Publications (2)

  • Hansen NM, Berg P, Rix M, Pareek M, Leipziger J, Kamper AL, Astrup A, Vaarby Sorensen M, Salomo L. The New Nordic Renal Diet Induces a Pronounced Reduction of Urine Acid Excretion and Uremic Toxins in Chronic Kidney Disease Patients (Stage 3 and 4). J Ren Nutr. 2023 May;33(3):412-419. doi: 10.1053/j.jrn.2022.09.010. Epub 2022 Oct 3.

  • Engel S, Elhauge M, Tholstrup T. Effect of whole milk compared with skimmed milk on fasting blood lipids in healthy adults: a 3-week randomized crossover study. Eur J Clin Nutr. 2018 Feb;72(2):249-254. doi: 10.1038/s41430-017-0042-5. Epub 2017 Dec 11.

MeSH Terms

Conditions

Atherosclerosis

Condition Hierarchy (Ancestors)

ArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Tine Tholstrup, Ass Prof.

    Department of Nutrition, Exercise and Sports, Univeristy of Copenhagen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 8, 2017

First Posted

February 14, 2017

Study Start

October 1, 2015

Primary Completion

December 1, 2015

Study Completion

July 1, 2016

Last Updated

April 2, 2018

Record last verified: 2018-03

Locations